BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6779006)

  • 1. Studies on several 7-substituted N,N-dimethyltryptamines.
    Glennon RA; Schubert E; Jacyno JM; Rosecrans JA
    J Med Chem; 1980 Nov; 23(11):1222-6. PubMed ID: 6779006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a novel series of N,N-dimethylisotryptamines.
    Glennon RA; Jacyno JM; Young R; McKenney JD; Nelson D
    J Med Chem; 1984 Jan; 27(1):41-5. PubMed ID: 6581313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogues.
    Glennon RA; Liebowitz SM; Mack EC
    J Med Chem; 1978 Aug; 21(8):822-5. PubMed ID: 278843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallucinogenic agents as discriminative stimuli: a correlation with serotonin receptor affinities.
    Glennon RA; Young R; Rosecrans JA; Kallman MJ
    Psychopharmacology (Berl); 1980; 68(2):155-8. PubMed ID: 6776558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives.
    Kline TB; Benington F; Morin RD; Beaton JM; Glennon RA; Domelsmith LN; Houk KN; Rozeboom MD
    J Med Chem; 1982 Nov; 25(11):1381-3. PubMed ID: 6815326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterparts.
    Glennon RA; Young R; Benington F; Morin RD
    Life Sci; 1982 Feb; 30(5):465-7. PubMed ID: 6801410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo long-term kinetics of radiolabeled n,n-dimethyltryptamine and tryptamine.
    Vitale AA; Pomilio AB; CaƱellas CO; Vitale MG; Putz EM; Ciprian-Ollivier J
    J Nucl Med; 2011 Jun; 52(6):970-7. PubMed ID: 21622895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats.
    Walters JK; Sheard MH; Davis M
    Pharmacol Biochem Behav; 1978 Jul; 9(1):87-90. PubMed ID: 279938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
    Commissaris RL; Davis M
    Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat.
    Schreiber R; de Vry J
    J Pharmacol Exp Ther; 1993 May; 265(2):572-9. PubMed ID: 8496807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
    Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs.
    Glennon RA; Gessner PK
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):453-65. PubMed ID: 270770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
    Deliganis AV; Pierce PA; Peroutka SJ
    Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine.
    Yanai K; Ido T; Ishiwata K; Hatazawa J; Takahashi T; Iwata R; Matsuzawa T
    Eur J Nucl Med; 1986; 12(3):141-6. PubMed ID: 3489620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral properties of psychoactive phenylisopropylamines in rats.
    Glennon RA; Rosecrans JA; Young R
    Eur J Pharmacol; 1981 Dec; 76(4):353-60. PubMed ID: 7327208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on hallucinogens. II. Synthesis of N,N-dimethyltryptamine (DMT) and its related compounds (author's transl)].
    Ono M; Shimamine M; Takahashi K
    Eisei Shikenjo Hokoku; 1973; 91(0):36-8. PubMed ID: 4527540
    [No Abstract]   [Full Text] [Related]  

  • 17. DOM and related 2,5-dimethoxy-4-alkylphenylisopropylamines: behavioral and serotonin receptor properties.
    Glennon RA; Doot DL; Young R
    Pharmacol Biochem Behav; 1981 Mar; 14(3):287-92. PubMed ID: 7232455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine.
    Young R; Rosecrans JA; Glennon RA
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1207-10. PubMed ID: 3809222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
    Glennon RA; Young R; Benington F; Morin RD
    J Med Chem; 1982 Oct; 25(10):1163-8. PubMed ID: 7143352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
    Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
    Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.